$3,06
▼ $-0,09
(-2,86%)
Vol 4.7M
5
Skor Kualitas
fail
Pendapatan ✗
Laba Bersih ✗
>IPO ✗
Kap. Pasar
$524.8M
ROE
-60,2%
Margin
-4071,2%
D/E
0,65
Beta
2,15
52W
$2–$6
Konsensus Wall Street
15 analis · Apr 20263
Beli Kuat
10
Beli
2
Tahan
0
Jual
0
Jual Kuat
86,7%
Peringkat Beli
Grafik Harga
Saham Serupa
Pendapatan
Tingkat beat: 40,0%
Laporan Berikutnya
Mei 11, 2026
Estimasi EPS: $-0,20
| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Mar 2026 | $-0,20 | — | — |
| Des 2025 | $-0,20 | $-0,20 | $0,00 |
| Sep 2025 | $-0,22 | $-0,20 | +$0,02 |
| Jun 2025 | $-0,22 | $-0,24 | $-0,02 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Pendapatan | $1.7M | $665K | $1.2M | $593K | $378K |
| Laba Bersih | -$27.4M | -$29.0M | -$26.3M | -$30.6M | -$28.7M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -60.2% | -60.2% | -60.2% | -60.2% | -60.2% | -60.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -5155.0% | -2737.9% | -2737.9% | -2737.9% | -4071.2% | -4071.2% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 1.24 | 1.24 | 1.24 | 1.24 | 0.65 | 0.65 |
| Current Ratio | 4.39 | 4.39 | 4.39 | 4.39 | 5.89 | 5.89 |
Rasio Utama
ROA (TTM)
-50,9%
P/S (TTM)
186,43
P/B
1,7
EPS (TTM)
$-0,90
CF/Share
$-1,01
Pertumbuhan Pendapatan 3T
-1,8%
52W High
$6,33
52W Low
$2,01
$2,01
Rentang 52 Minggu
$6,33
Kesehatan Keuangan
Arus Kas Bebas
-$26.0M
Utang Bersih
-$3.3M
Kas
$9.5M
Total Utang
$6.2M
Per tanggal Sep 30, 2025
Як ABSI виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка ABSI vs аналоги Biotechnology
P/E
—
▼
0%
di bawah
rekan
(18,8)
vs Rekan
vs Industri
Undervalued
P/S
186,4
▲
1351%
di atas
rekan
(12,9)
vs Rekan
vs Industri
Lebih mahal
P/B
1,7
▼
32%
di bawah
rekan
(2,5)
vs Rekan
vs Industri
Lebih mahal
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,0%)
vs Rekan
vs Industri
Yield rendah
Прибутковість ABSI vs аналоги Biotechnology
ROE
-60,2%
▲
11%
di atas
rekan
(-67,3%)
vs Rekan
vs Industri
Sejajar
Net margin
-4071,2%
▼
1320%
di bawah
rekan
(-286,8%)
vs Rekan
vs Industri
Lemah
Валова маржа
—
▼
0%
di bawah
rekan
(78,6%)
vs Rekan
vs Industri
Sejajar
ROA
-50,9%
▼
9%
di bawah
rekan
(-46,7%)
vs Rekan
vs Industri
Sejajar
Фінансове здоровʼя ABSI vs аналоги Biotechnology
D/E ratio
0,7
▼
0%
di bawah
rekan
(0,0)
vs Rekan
vs Industri
Sejajar
Поточна ліквідність
5,9
▲
33%
di atas
rekan
(4,4)
vs Rekan
vs Industri
Di bawah rata-rata
Beta
2,2
▲
122%
di atas
rekan
(1,0)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів ABSI
ABSI
Median rekan
Industri
ABSI прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
ABSI vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
BUSCH ANDREAS
Officer · Mar 12
100000 shs
MCCLAIN SEAN
Chief Executive Officer · Mar 02
406200 shs
MCCLAIN SEAN
Chief Executive Officer · Mar 02
406200 shs
BEDRICK TODD
Officer · Mar 02
49600 shs
BEDRICK TODD
Officer · Mar 02
49600 shs
JONASSON ZACHARIAH
Chief Financial Officer · Mar 02
135400 shs
JONASSON ZACHARIAH
Chairman of the Board · Mar 02
135400 shs
WALKER SHELBY J
Officer · Mar 02
90300 shs
WALKER SHELBY J
Officer · Mar 02
90300 shs
PANGALOS MENELAS N
Director · Mar 02
5800 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 41,52%FMR, LLC
14,88%
$62.2M
ARK Investment Management, …
8,35%
$34.9M
Blackrock Inc.
7,54%
$31.5M
Redmile Group, LLC
5,49%
$22.9M
Vanguard Group Inc
5,26%
$22.0M
Per tanggal Des 31, 2025
Berita Terbaru
Belum ada berita terkait